Farah Moustafa, MD
Dermatology · Providence, RINPI 1679954853
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $45,594 of the $51,333 with a category attached, or 88.8%. Lilly USA, LLC accounts for 96.6% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2024 at $30,209 and has fallen 98.9% since, to $335 in 2025. Among dermatology clinicians in RI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 97 payments — averaging $529.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$50K
- Galderma Laboratories, L.p.$541
- AbbVie$511
- Merz North America, Inc.$188
- Johnson & Johnson$97
- E.r. Squibb & Sons, L.L.C.$75
- plus $334 from 10 others
What the payments were for
- Speaking & faculty fees$45,59489%
- Travel & lodging$3,4527%
- Food & beverage$2,1104%
- Education$1770%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 51 | $49,586 |
| Galderma Laboratories, L.p. | 8 | $541 |
| AbbVie(2 entities) | 16 | $511 |
| Merz North America, Inc. | 4 | $188 |
| Johnson & Johnson | 2 | $97 |
| E.r. Squibb & Sons, L.L.C. | 2 | $75 |
| Novartis | 3 | $71 |
| Organon | 3 | $65 |
| Mentor Worldwide LLC | 1 | $32 |
| Amgen | 1 | $32 |
| Sanofi | 1 | $24 |
| Bristol Myers Squibb | 1 | $24 |
| Mission Pharmacal Company | 1 | $24 |
| Pfizer | 1 | $24 |
| UCB, Inc. | 1 | $20 |
| Sun Pharmaceutical Industries Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$51,333 in reported general payments places this provider in the 95th percentile of 61 dermatology providers in Rhode Island.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Minoxidil | 18 | $234 |
| Finasteride | 15 | $164 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Providence
- Helena KuhnProvidence$63K
- Martin WeinstockProvidence$62K
- Abrar QureshiProvidence$38K
- Scott HammermanProvidence$9K
- Laura della TorreProvidence$9K
- Benjamin KahnProvidence$4K
- Rachel HoffmannProvidence$4K
- Jennie MugliaProvidence$2K
- Daniella ReimannProvidence$2K
- Gladys TelangProvidence$624
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.